Stock Screener App

Frei -

Installieren

7.37

0.27% 0.02

Sagimet Biosciences Inc (SGMT)

Überblick Nachrichten Preisverlauf Forum Prognose

Sagimet Biosciences Inc Aktie (SGMT) Neueste Nachrichten

Sagimet Biosciences(SGMT) Stock Options Chain | Quotes & News - Moomoo

Price to earnings forward of Sagimet Biosciences Inc.Series A – NASDAQ:SGMT - TradingView

Enterprise value to EBIT forward of Sagimet Biosciences Inc. Class A – SWB:0O2 - TradingView

Sagimet Biosciences (SGMT) Financials 2026Income Statement and Balance Sheet - MarketBeat

Sagimet Biosciences to join Russell 3000 and Russell 2000 as part of 2026 index reconstitution - Traders Union

JonesTrading Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Raises Target Price to $31 - Moomoo

Sagimet Therapeutics: Buy Rating Affirmed as Clinically De‑Risked FASN Franchise Advances; Price Target Raised to $31 - TipRanks

Sagimet Biosciences Inc.(NasdaqGM:SGMT) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Sagimet Biosciences Inc.(NasdaqGM: SGMT) added to Russell 2500 Growth Benchmark - marketscreener.com

Sagimet Biosciences Added to Russell Indexes - marketscreener.com

Sagimet Biosciences Inc.(NasdaqGM: SGMT) added to Russell 2000 Index - marketscreener.com

Sagimet Biosciences added to Russell 2000 and 3000 indexes By Investing.com - Investing.com South Africa

Sagimet Biosciences Inc.(NasdaqGM: SGMT) added to Russell 2000 Value Benchmark - marketscreener.com

Sagimet Biosciences Inc. Class A Actuals & Estimates (NASDAQ:SGMT) - TradingView

Sagimet Biosciences Inc.(NasdaqGM:SGMT) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Sagimet Biosciences (SGMT) Joins Russell 3000 and Russell 2000 I - GuruFocus

Sagimet Biosciences added to Russell 2000 and 3000 indexes - Investing.com

Sagimet Biosciences Inc.(NasdaqGM: SGMT) added to Russell 2000 Growth Benchmark - marketscreener.com

Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes - GlobeNewswire

Sagimet Biosciences Inc.(NasdaqGM: SGMT) added to Russell 3000E Growth Benchmark - marketscreener.com

Sagimet Biosciences Inc.(NasdaqGM: SGMT) added to Russell 2500 Index - marketscreener.com

Price to earnings forward of Sagimet Biosciences Inc. Class A – LS:A3CPAM - TradingView

Sagimet Biosciences Inc.(NasdaqGM: SGMT) added to Russell 3000E Value Benchmark - marketscreener.com

SGMT Stock Surged 40% And Breached 200-DMA For The First Time In Nearly 3 Months – What’s Got Retail Buzzing? - Stocktwits

Enterprise value to EBITDA forward of Sagimet Biosciences Inc.Series A – NASDAQ:SGMT - TradingView

Enterprise value to EBIT forward of Sagimet Biosciences Inc. Class A – LS:A3CPAM - TradingView

Enterprise value to EBITDA forward of Sagimet Biosciences Inc. Class A – LS:A3CPAM - TradingView

Price to book forward of Sagimet Biosciences Inc.Series A – NASDAQ:SGMT - TradingView

Price to sales forward of Sagimet Biosciences Inc.Series A – NASDAQ:SGMT - TradingView

Enterprise value to revenue forward of Sagimet Biosciences Inc.Series A – NASDAQ:SGMT - TradingView

Price to sales forward of Sagimet Biosciences Inc. Class A – LS:A3CPAM - TradingView

Sagimet Biosciences Inc (SGMT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

0O2 Forecast — Price Target — Prediction for 2027 - TradingView

SGMT Forecast — Price Target — Prediction for 2027 - TradingView

Sagimet Biosciences (SGMT) Short Interest & Short Float | Updated Jun 2026 - MarketBeat

Sagimet Biosciences Inc (SGMT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Wall Street Analysts Believe Sagimet Biosciences Inc. (SGMT) Could Rally 298.5%: Here's is How to Trade - Eastern Progress

Sagimet Biosciences Inc.(NasdaqGM:SGMT) added to S&P Biotechnology Select Industry Index - marketscreener.com

Sagimet Biosciences (SGMT) Edges Higher as Biotech Sector Gains MomentumZigzag Correction - dars.gov.et

SGMT Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive ReactionDividend Growth Analysis - dars.gov.et

SGMT News | SAGIMET BIOSCIENCES INC-A (NASDAQ:SGMT) - ChartMill

Sagimet: Buy Rating Reiterated as Denifanstat Advances and $28 Price Target Remains Unchanged - TipRanks

Wedbush Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $28 - Moomoo

Sagimet Biosciences Inc (SGMT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Sagimet Biosciences Inc (SGMT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Sagimet Biosciences Inc (SGMT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

SGMT SEC FilingsSagimet Biosciences Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Sagimet Biosciences Inc (SGMT) Valuation: PE, PB & Fair Value Analysis - TradingKey

Sagimet Biosciences Inc (SGMT) Institutional Confidence - TradingKey

Sagimet Biosciences Inc (SGMT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Sagimet Biosciences (SGMT) director receives 39,567 stock options grant - Stock Titan

Sagimet Biosciences (SGMT) director receives stock option grant for 39,567 shares - Stock Titan

Director at Sagimet Biosciences (NASDAQ: SGMT) receives 39,567 stock options - Stock Titan

Sagimet Biosciences (SGMT) director receives 39,567 stock options at $6.48 - Stock Titan

Sagimet Biosciences (SGMT) grants director Kemble George 39,567 stock options - Stock Titan

RPRX

$56.43

2.64%

INSM

$115.61

2.24%

ROIV

$35.97

2.28%

MRNA

$68.27

10.83%

ONC

$298.70

1.36%

RVMD

$186.88

2.22%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters